# ASSEMBLY BIOSCIENCES, INC.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:0d38b2e6-7580-4c06-914c-0652911da6e9 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/assembly-biosciences-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 21 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-21T04:46:23.114919+00:00 |
| Last reviewed | 2026-10-21T04:46:23.114919+00:00 |

## Identity

- Legal name: ASSEMBLY BIOSCIENCES, INC.
- Display name: ASSEMBLY BIOSCIENCES, INC.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-21T22:38:04.054637+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.846 |
| Directors | 9 |
| Committees | 4 |
| Governance events | 16 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Anthony E. Altig: Director. Status: current. Independent: true. Since: 2012-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:5
- Gina Consylman: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:6
- Jason A. Okazaki: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:7
- John G. McHutchison, A.O., M.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:8
- Lisa R. Johnson-Pratt, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:9
- Robert D. Cook II: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:10
- Sir Michael Houghton, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:11
- Susan Mahony, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:12
- Tomas Cihlar, Ph.D.: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:13

## Committees

- Audit (audit). Chair: Anthony E. Altig. Members: Anthony E. Altig (chair, current); Gina Consylman (member, current). committee_id=alpha:committee:assembly-biosciences-inc:audit
- Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Anthony E. Altig (member, current). committee_id=alpha:committee:assembly-biosciences-inc:audit-chair
- Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Gina Consylman (member, current). committee_id=alpha:committee:assembly-biosciences-inc:audit-compensation
- Compensation (compensation). Chair: NOT_PUBLISHED. Members: Gina Consylman (member, current). committee_id=alpha:committee:assembly-biosciences-inc:compensation

## Executive leadership

- Anuj Gaggar, M.D., Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:14
- Jason A. Okazaki: Named Executive Officer. Status: current. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:15
- William E. Delaney IV, Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:16

## Governance events

- EXECUTIVE_APPOINTED: Anuj Gaggar, M.D., Ph.D. executive of ASSEMBLY BIOSCIENCES, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1b0pyzp107mfuf
- EXECUTIVE_APPOINTED: Jason A. Okazaki executive of ASSEMBLY BIOSCIENCES, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:ohxjqtfnfrm1
- EXECUTIVE_APPOINTED: William E. Delaney IV, Ph.D. executive of ASSEMBLY BIOSCIENCES, INC., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1cxqh1c14yk7u
- DIRECTOR_APPOINTED: Robert D. Cook II seat on ASSEMBLY BIOSCIENCES, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:snqbsj1efetkz
- DIRECTOR_APPOINTED: Jason A. Okazaki seat on ASSEMBLY BIOSCIENCES, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:9tftcccyjwwu
- DIRECTOR_APPOINTED: Tomas Cihlar, Ph.D. seat on ASSEMBLY BIOSCIENCES, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:bw8j7rw9xfjj
- DIRECTOR_APPOINTED: Lisa R. Johnson-Pratt, M.D. seat on ASSEMBLY BIOSCIENCES, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1t0ft6avchr06
- DIRECTOR_APPOINTED: Sir Michael Houghton, Ph.D. seat on ASSEMBLY BIOSCIENCES, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:7lvq6d13ws9bf
- DIRECTOR_APPOINTED: Gina Consylman seat on ASSEMBLY BIOSCIENCES, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1pxjii25cxcfg
- COMMITTEE_CREATED: Audit; Compensation committee of ASSEMBLY BIOSCIENCES, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:tyank21w8qrms
- COMMITTEE_MEMBER_ADDED: Gina Consylman member of Audit; Compensation, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1sd2vpgmwcbcu
- DIRECTOR_APPOINTED: John G. McHutchison, A.O., M.D. seat on ASSEMBLY BIOSCIENCES, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1k54hysh9vsx8
- DIRECTOR_APPOINTED: Susan Mahony, Ph.D. seat on ASSEMBLY BIOSCIENCES, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:19mjalh1ans4tt
- DIRECTOR_APPOINTED: Anthony E. Altig seat on ASSEMBLY BIOSCIENCES, INC., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:1krxay8dfgmhi
- COMMITTEE_CREATED: Audit · Chair committee of ASSEMBLY BIOSCIENCES, INC., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:rj1xlkvx6946
- COMMITTEE_MEMBER_ADDED: Anthony E. Altig member of Audit · Chair, effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-21T04:46:23.114919+00:00. event_id=alpha:event:transition:q5ob6vvtwpfd

## Scoped resources

- `alpha://company/assembly-biosciences-inc` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record
- `alpha://company/assembly-biosciences-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=identity
- `alpha://company/assembly-biosciences-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=corporate-structure
- `alpha://company/assembly-biosciences-inc/board` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=board
- `alpha://company/assembly-biosciences-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=committees
- `alpha://company/assembly-biosciences-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=leadership
- `alpha://company/assembly-biosciences-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=ownership
- `alpha://company/assembly-biosciences-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=financials
- `alpha://company/assembly-biosciences-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=capital-structure
- `alpha://company/assembly-biosciences-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=compensation
- `alpha://company/assembly-biosciences-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=governance
- `alpha://company/assembly-biosciences-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=shareholder-governance
- `alpha://company/assembly-biosciences-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=audit
- `alpha://company/assembly-biosciences-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=legal
- `alpha://company/assembly-biosciences-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=risk
- `alpha://company/assembly-biosciences-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=cyber
- `alpha://company/assembly-biosciences-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=ai-governance
- `alpha://company/assembly-biosciences-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=agents
- `alpha://company/assembly-biosciences-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=ecosystem
- `alpha://company/assembly-biosciences-inc/events` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=events
- `alpha://company/assembly-biosciences-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=relationships
- `alpha://company/assembly-biosciences-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=assessments
- `alpha://company/assembly-biosciences-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:anthony-e-altig","name":"Anthony E. Altig"},"source_id":"board_seats"}`
- Claim alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:gina-consylman","name":"Gina Consylman"},"source_id":"board_seats"}`
- Claim alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:gina-consylman","name":"Gina Consylman"},"source_id":"board_seats"}`

## Leadership

- Anthony E. Altig: Director, Audit · Chair. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:5. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Gina Consylman: Director, Audit; Compensation. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Jason A. Okazaki: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- John G. McHutchison, A.O., M.D.: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Lisa R. Johnson-Pratt, M.D.: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Robert D. Cook II: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Sir Michael Houghton, Ph.D.: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Susan Mahony, Ph.D.: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:12. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Tomas Cihlar, Ph.D.: Director. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:13. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d.
- Anuj Gaggar, M.D., Ph.D.: Named Executive Officer. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:14. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9236d5f9073d1bf0d9e447bb812542f59f0fbdfab6d535df89904dd778b2b288.
- Jason A. Okazaki: Named Executive Officer. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:15. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:04a9fa87452f7cab8edb9aa173082112acaa2dad57227688f9b3e0de3f7f0d35.
- William E. Delaney IV, Ph.D.: Named Executive Officer. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:leadership_role:16. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5215d6c9bdb79624585ca4b882db6a435134dddcf400df80c611756867d2ddb.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Anthony E. Altig; Members Anthony E. Altig (Chair); Gina Consylman. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d219793dfecf863df65aa17e2331c75ac290709af1391e6392815b3832754ca1.
- Compensation: Chair not stated; Members Gina Consylman. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d219793dfecf863df65aa17e2331c75ac290709af1391e6392815b3832754ca1.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- ASSEMBLY BIOSCIENCES, INC.. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca18fd204c450f140f2403f98e81ee5003dd8a3cd52c7dc731067baa6b0dadd9.

## Entity Status

- Public listing published. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca18fd204c450f140f2403f98e81ee5003dd8a3cd52c7dc731067baa6b0dadd9.

## Published Fact

- US. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca18fd204c450f140f2403f98e81ee5003dd8a3cd52c7dc731067baa6b0dadd9.

## Committee Appointment

- Anthony E. Altig: chair, Audit. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d219793dfecf863df65aa17e2331c75ac290709af1391e6392815b3832754ca1.
- Gina Consylman: member, Audit. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d219793dfecf863df65aa17e2331c75ac290709af1391e6392815b3832754ca1.
- Gina Consylman: member, Compensation. Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d219793dfecf863df65aa17e2331c75ac290709af1391e6392815b3832754ca1.

## Security Listing

- ASMB (NASDAQ). Claim: alpha:claim:company:0d38b2e6-7580-4c06-914c-0652911da6e9:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca18fd204c450f140f2403f98e81ee5003dd8a3cd52c7dc731067baa6b0dadd9.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:ca18fd204c450f140f2403f98e81ee5003dd8a3cd52c7dc731067baa6b0dadd9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/assembly-biosciences-inc).
- alpha:projection-evidence:document:b5fbb04400e16ef511b339238ec9474dab7541b0ea7583a1d26e322f426d305d: [ASSEMBLY BIOSCIENCES, INC. DEF 14A 2026-04-22](https://www.sec.gov/Archives/edgar/data/1426800/000119312526170417/asmb-20260421.htm).
- alpha:projection-evidence:document:9236d5f9073d1bf0d9e447bb812542f59f0fbdfab6d535df89904dd778b2b288: [ASMB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1426800/000119312526170417/asmb-20260421.htm).
- alpha:projection-evidence:document:04a9fa87452f7cab8edb9aa173082112acaa2dad57227688f9b3e0de3f7f0d35: [ASMB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1426800/000119312526170417/asmb-20260421.htm).
- alpha:projection-evidence:document:b5215d6c9bdb79624585ca4b882db6a435134dddcf400df80c611756867d2ddb: [ASMB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1426800/000119312526170417/asmb-20260421.htm).
- alpha:projection-evidence:d219793dfecf863df65aa17e2331c75ac290709af1391e6392815b3832754ca1: [Audit](https://www.sec.gov/Archives/edgar/data/1426800/000119312526170417/asmb-20260421.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/assembly-biosciences-inc)
- [Public Markdown](https://registry.alpha.ac/companies/assembly-biosciences-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/assembly-biosciences-inc?format=jsonld)
- MCP resource: `alpha://companies/assembly-biosciences-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-21T22:38:03.623904+00:00; recorded 2026-10-21T22:38:03.623904+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.